$6.45
+0.24 (+3.86%)
Open$6.25
Previous Close$6.21
Day High$6.50
Day Low$6.12
52W High$23.20
52W Low$3.51
Volume—
Avg Volume2.24M
Market Cap775.94M
P/E Ratio—
EPS$-2.58
SectorPharmaceuticals
Analyst Ratings
Hold
17 analysts
Price Target
+556.1% upside
Current
$6.45
$6.45
Target
$42.32
$42.32
$27.22
$42.32 avg
$56.32
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 103.89M | 95.02M | 180.40M |
| Net Income | -276,600,363 | -227,675,440 | 49.45M |
| Profit Margin | -266.3% | -252.9% | 27.4% |
| EBITDA | -274,010,156 | -238,073,576 | 94.91M |
| Free Cash Flow | — | — | 60.57M |
| Rev Growth | +9.3% | +9.3% | -1.4% |
| Debt/Equity | 0.20 | 0.20 | 0.60 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |